Skip to main content

Moderna testing potential monkeypox vaccines

Share

Moderna Inc is testing potential vaccines against monkeypox in pre-clinical trials as the disease spreads in the United States and Europe.

The World Health Organization said on Tuesday there have been 131 confirmed monkeypox cases and 106 further suspected cases since the first was reported on May 7 outside the countries where it usually spreads.

Moderna did not immediately respond to a request for more details on the monkeypox vaccines.

The U.S. Centers for Disease Control and Prevention said the government was in the process of releasing doses of a smallpox vaccine Jynneos, made by Bavarian Nordic A/S BAVA.CO, for use in monkeypox cases.

Reporting by Leroy Leo in Bengaluru; Editing by Shounak Dasgupta

CTVNews.ca Top Stories

opinion

opinion Harry and Meghan's Nigerian adventure: Traditional attire to warm welcomes

For her latest column on CTVNews.ca, royal commentator Afua Hagan writes about Prince Harry and Meghan Markle's recent visit to Nigeria, calling it a 'deeply meaningful campaign' that was about aligning their ongoing efforts to foster mental-health awareness and promoting the Invictus Games.

Local Spotlight